Study title:
Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the counter antihistamines, ibuprofen and clemasine, Pratt, C.M., Am. J. Cardiol. 1994; 73: 346-352Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the counter antihistamines, ibuprofen and clemasine, Pratt, C.M., Am. J. Cardiol. 1994; 73: 346-352
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Immune System Diseases [C20]
|
Brands: |
MAH holders: Please see report |
Assessment: |
Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|